SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027200
Filing Date
2021-05-13
Accepted
2021-05-13 07:07:43
Documents
76
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 Q1 2021 10-Q ortx-10q_20210331.htm   iXBRL 10-Q 2911738
2 EX-31.1 ortx-ex311_6.htm EX-31.1 19286
3 EX-31.2 ortx-ex312_7.htm EX-31.2 19259
4 EX-32.1 ortx-ex321_11.htm EX-32.1 12413
  Complete submission text file 0001564590-21-027200.txt   9720255

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ortx-20210331.xsd EX-101.SCH 63329
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ortx-20210331_cal.xml EX-101.CAL 67924
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ortx-20210331_def.xml EX-101.DEF 160859
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ortx-20210331_lab.xml EX-101.LAB 458207
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ortx-20210331_pre.xml EX-101.PRE 336373
10 EXTRACTED XBRL INSTANCE DOCUMENT ortx-10q_20210331_htm.xml XML 1825913
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38722 | Film No.: 21917159
SIC: 2836 Biological Products, (No Diagnostic Substances)